Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Oct;174(20):3466-3481.
doi: 10.1111/bph.13732. Epub 2017 Mar 16.

Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function

Affiliations
Review

Exercise effects on perivascular adipose tissue: endocrine and paracrine determinants of vascular function

B C S Boa et al. Br J Pharmacol. 2017 Oct.

Abstract

Obesity is a global epidemic, accompanied by increased risk of type 2 diabetes and cardiovascular disease. Adipose tissue hypertrophy is associated with adipose tissue inflammation, which alters the secretion of adipose tissue-derived bioactive products, known as adipokines. Adipokines determine vessel wall properties such as smooth muscle tone and vessel wall inflammation. Exercise is a mainstay of prevention of chronic, non-communicable diseases, type 2 diabetes and cardiovascular disease in particular. Aside from reducing adipose tissue mass, exercise has been shown to reduce inflammatory activity in this tissue. Mechanistically, contracting muscles release bioactive molecules known as myokines, which alter the metabolic phenotype of adipose tissue. In adipose tissue, myokines induce browning, enhance fatty acid oxidation and improve insulin sensitivity. In the past years, the perivascular adipose tissue (PVAT) which surrounds the vasculature, has been shown to control vascular tone and inflammation through local release of adipokines. In obesity, an increase in mass and inflammation of PVAT culminate in dysregulation of adipokine secretion, which contributes to vascular dysfunction. This review describes our current understanding of the mechanisms by which active muscles interact with adipose tissue and improve vascular function. Aside from the exercise-dependent regulation of canonical adipose tissue function, we will focus on the interactions between skeletal muscle and PVAT and the role of novel myokines, such as IL-15, FGF21 and irisin, in these interactions.

Linked articles: This article is part of a themed section on Molecular Mechanisms Regulating Perivascular Adipose Tissue - Potential Pharmacological Targets? To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v174.20/issuetoc.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Central and paracrine control of the PVAT by exercise. Juxtaposition of PVAT, nerves CNS, SKM and microvessels in a transverse section of the mouse hindlimb and mechanisms of interaction with AT. First, central effects of exercise are exerted through noradrenaline from sympathetic nerve fibres, with subsequent beiging and vasodilator function of PVAT. Second, muscle activity regulates (perivascular) AT function through myokines such as FGF‐21, metrnl, irisin, IL‐15, IL‐6, acting in a paracrine fashion to antagonize dysfunction of AT (i.e. inflammation and dysregulated secretion of adipokines).
Figure 2
Figure 2
Signalling pathways involved in dysfunction of AT and effects of exercise. HFD feeding and a sedentary lifestyle change AT morphology, such as adipocyte hypertrophy and hyperplasia. Subsequently, AT shows hypoperfusion, inflammation and remodelling, with consequent inflammatory cell infiltration and abnormal secretion of inflammatory adipokines. Exercise exerts an anti‐inflammatory effect on dysfunctional AT. It activates the CNS and stimulates release of myokines, resulting in a reduced AT mass and an improved functional and metabolic phenotype. βAR, β‐adrenoceptors.

References

    1. Abate N, Garg A (1995). Heterogeneity in adipose tissue metabolism: causes, implications and management of regional adiposity. Prog Lipid Res 34: 53–70. - PubMed
    1. Albrecht E, Norheim F, Thiede B, Holen T, Ohashi T, Schering L et al. (2015). Irisin – a myth rather than an exercise‐inducible myokine. Sci Rep 5: 8889. - PMC - PubMed
    1. Alexander SPH, Cidlowski JA, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015a). The Concise Guide to PHARMACOLOGY 2015/16: Nuclear hormone receptors. Br J Pharmacol 172: 5956–5978. - PMC - PubMed
    1. Alexander SPH, Kelly E, Marrion N, Peters JA, Benson HE, Faccenda E et al. (2015b). The Concise Guide to PHARMACOLOGY 2015/16: Transporters. Br J Pharmacol 172: 6110–6202. - PMC - PubMed
    1. Alexander SPH, Fabbro D, Kelly E, Marrion N, Peters JA, Benson HE et al. (2015c). The Concise Guide to PHARMACOLOGY 2015/16: Catalytic receptors. Br J Pharmacol 172: 5979–6023. - PMC - PubMed

MeSH terms

Substances